Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Roques

Showing results (421-430 of 558) with videos related to

Pageof 56
Sort By:
European Journal of Pharmacology|June 5, 1992
Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonistL A Tive, C G Pick, D Paul, et al.
Life Sciences|October 29, 1979
Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: further evidence for the involvement of carboxydipeptidaseA Guyon, B P Roques, F Guyon, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|November 14, 1997
Synthesis and biological activities of fluorescent acridine-containing HIV-1 nucleocapsid proteins for investigation of nucleic acid-NCp7 interactionsC Z Dong, H De Rocquigny, E Rémy, et al.
Life Sciences|December 30, 1985
[3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreasD Pélaprat, J M Zajac, G Gacel, et al.
Journal of Medicinal Chemistry|October 1, 1993
Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical propertiesA G Blommaert, J H Weng, A Dorville, et al.
Biopolymers|March 1, 1997
Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid proteinS P Stoylov, C Vuilleumier, E Stoylova, et al.
British Journal of Pharmacology|January 12, 1999
Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinolD M Hutcheson, E T Tzavara, C Smadja, et al.
Journal of Medicinal Chemistry|June 26, 1992
"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymesM C Fournié-Zaluski, P Coric, S Turcaud, et al.
Pain|February 13, 2001
Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respirationE Boudinot, M Morin-Surun, A S Foutz, et al.
European Journal of Cell Biology|December 1, 1994
Fate of a fluorescent inhibitor of endopeptidase-24.11 using enzyme-expressing MDCK cells. Modification of its cellular processing with a monoclonal antibodyP E Milhiet, M C Giocondi, P Crine, et al.
Pageof 56

Showing results (421-430 of 558) with videos related to

Sort By:
Pageof 56
European Journal of Pharmacology|June 5, 1992
Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonistL A Tive, C G Pick, D Paul, et al.
Life Sciences|October 29, 1979
Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: further evidence for the involvement of carboxydipeptidaseA Guyon, B P Roques, F Guyon, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|November 14, 1997
Synthesis and biological activities of fluorescent acridine-containing HIV-1 nucleocapsid proteins for investigation of nucleic acid-NCp7 interactionsC Z Dong, H De Rocquigny, E Rémy, et al.
Life Sciences|December 30, 1985
[3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreasD Pélaprat, J M Zajac, G Gacel, et al.
Journal of Medicinal Chemistry|October 1, 1993
Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical propertiesA G Blommaert, J H Weng, A Dorville, et al.
Biopolymers|March 1, 1997
Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid proteinS P Stoylov, C Vuilleumier, E Stoylova, et al.
British Journal of Pharmacology|January 12, 1999
Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinolD M Hutcheson, E T Tzavara, C Smadja, et al.
Journal of Medicinal Chemistry|June 26, 1992
"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymesM C Fournié-Zaluski, P Coric, S Turcaud, et al.
Pain|February 13, 2001
Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respirationE Boudinot, M Morin-Surun, A S Foutz, et al.
European Journal of Cell Biology|December 1, 1994
Fate of a fluorescent inhibitor of endopeptidase-24.11 using enzyme-expressing MDCK cells. Modification of its cellular processing with a monoclonal antibodyP E Milhiet, M C Giocondi, P Crine, et al.
Pageof 56